The eventual combination of cagrlintide and tirzepatide is primarily targeted at adults with type 2 diabetes who also struggle with obesity or weight management challenges
The thing that makes me hesitant is the supposed mode of action - GLP-1RA are supposed to boost insulin not an effect Im interested in
Both medications share comparable safety profiles, with common gastrointestinal side effects including nausea, vomiting, diarrhea, and abdominal pain that are generally mild to moderate and resolve as the body adjusts
These are sometimes complicated cases
For example, Joe Rogan, a well-known commentator and fitness advocate, has spoken about BPC 157 peptide on his podcast, citing its impressive regenerative potential
Its primary function is to help protect cells from oxidative stress by neutralising harmful free radicals